Mode
Text Size
Log in / Sign up

Systematic review outlines EPI-DOM framework for assessing welfare in tilapia across laboratory and production systems.

Systematic review outlines EPI-DOM framework for assessing welfare in tilapia across laboratory and …
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider the EPI-DOM framework as an operational guide for assessing tilapia welfare in laboratory and production settings.

A systematic review examined the EPI-DOM framework designed for assessing fish welfare specifically in tilapia. The study population included tilapia housed in both laboratory and production systems, such as farms and laboratories. The review did not report a specific sample size or follow-up duration. The primary outcome involved the classification of external and internal indicators alongside the definition of adverse welfare events (AWE).

secondary outcomes assessed included the organization of risk factors within the Management domain, linking indicators to risk factors through cross-mapping, and the prioritization of interventions. The framework also addressed the contextual interpretation of body integrity, physiological, and biochemical ranges, harmonization of units and methods, and the design of practical sampling schemes. No comparator was reported for this assessment.

Safety and tolerability data were not reported in the review. Adverse events, serious adverse events, discontinuations, and general tolerability metrics were not provided. The review did not report specific limitations regarding study design or data completeness. Funding sources and potential conflicts of interest were not reported.

The practice relevance of this review is that it provides an operational guide to support welfare improvement in tilapia. This enables evidence-based decision-making and the implementation of good practices in both laboratory and field settings. Clinicians and researchers should interpret these findings as a structural approach to welfare assessment rather than a causal intervention with proven efficacy, given the lack of reported quantitative results and safety data.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
The EPI-DOM framework proposes an applied epidemiological approach to evaluate and manage tilapia welfare in laboratory and production systems, integrating animal-based indicators with risk factors organized into operational domains (management, environment, and interaction). An integrative review (2000–2025) was conducted and analytically structured under the EPI-DOM framework to: (i) classify external and internal indicators and define adverse welfare events (AWE); (ii) organize risk factors within the Management domain; and (iii) link indicators to risk factors through cross-mapping to prioritize interventions. Methodological criteria were incorporated for contextual interpretation of body integrity, physiological and biochemical ranges, harmonization of units/methods (for farms and laboratories), and the design of practical sampling schemes (population-level and sentinel) for farms. The final product is an operational guide that translates dispersed evidence into a replicable welfare assessment system, including domain-based risk matrices, checklists, and preventive/corrective action guidance to identify critical welfare points and support context-specific decision-making. EPI-DOM bridges welfare science and applied epidemiology by preserving traceability (indicator–risk–management–intervention), promoting comparability across systems, and allowing operational thresholds and sampling strategies to be adapted to local conditions without compromising methodological consistency. This EPI-DOM–aligned guide provides a dynamic, verifiable framework to support welfare improvement in tilapia, enabling evidence-based decision-making and implementation of good practices in both laboratory and field settings.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.